Literature DB >> 16631162

Ubc9 expression is essential for myotube formation in C2C12.

Cecilia Riquelme1, Kristen K B Barthel, Xiao-Feng Qin, Xuedong Liu.   

Abstract

Myogenic differentiation is a fundamental biological process that involves a hierarchical series of events that ultimately leads to muscle-specific gene expression and myofiber formation. Posttranslational modifications of the myogenic regulatory factors have been implicated as important regulatory mechanisms in this process. Here we investigate whether covalent protein modification by a small ubiquitin-like modifier (SUMO) that is known to affect transcription factor activity can impact muscle differentiation. We show that the overall load of sumoylated proteins present in myoblasts diminishes progressively throughout myogenesis. Interestingly, knockdown of the SUMO-conjugating enzyme, Ubc9, severely compromises C2C12 muscle cell terminal differentiation. However, it does not affect the expression, the localization and the activation of MyoD and myogenin. These novel results suggest that protein sumoylation plays a pivotal role in myoblast differentiation and is required to regulate the activity of key targets downstream of MyoD and myogenin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631162     DOI: 10.1016/j.yexcr.2006.03.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Myotube formation on micro-patterned glass: intracellular organization and protein distribution in C2C12 skeletal muscle cells.

Authors:  Daniel L Yamamoto; Robert I Csikasz; Yu Li; Gunjana Sharma; Klas Hjort; Roger Karlsson; Tore Bengtsson
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

2.  Defective sumoylation pathway directs congenital heart disease.

Authors:  Jun Wang; Li Chen; Shu Wen; Huiping Zhu; Wei Yu; Ivan P Moskowitz; Gary M Shaw; Richard H Finnell; Robert J Schwartz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-11

3.  Overexpression of SUMO perturbs the growth and development of Caenorhabditis elegans.

Authors:  Miia M Rytinki; Merja Lakso; Petri Pehkonen; Vuokko Aarnio; Kaja Reisner; Mikael Peräkylä; Garry Wong; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2011-01-21       Impact factor: 9.261

4.  Structural basis of selective ubiquitination of TRF1 by SCFFbx4.

Authors:  Zhixiong Zeng; Wei Wang; Yuting Yang; Yong Chen; Xiaomei Yang; J Alan Diehl; Xuedong Liu; Ming Lei
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

5.  Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.

Authors:  Jun Wang; AnKang Li; ZhiGao Wang; XinHua Feng; Eric N Olson; Robert J Schwartz
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

6.  Sumoylation dynamics during keratinocyte differentiation.

Authors:  Adeline F Deyrieux; Germán Rosas-Acosta; Michelle A Ozbun; Van G Wilson
Journal:  J Cell Sci       Date:  2006-12-12       Impact factor: 5.285

Review 7.  Ubiquitin proteolytic system: focus on SUMO.

Authors:  Van G Wilson; Phillip R Heaton
Journal:  Expert Rev Proteomics       Date:  2008-02       Impact factor: 3.940

8.  Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase G9a and function in myogenesis.

Authors:  Yaju Wang; Shilpa Rani Shankar; Devaki Kher; Belinda Mei Tze Ling; Reshma Taneja
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

9.  LongSAGE analysis of skeletal muscle at three prenatal stages in Tongcheng and Landrace pigs.

Authors:  Zhonglin Tang; Yong Li; Ping Wan; Xiaoping Li; Shuhong Zhao; Bang Liu; Bin Fan; Mengjin Zhu; Mei Yu; Kui Li
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways.

Authors:  Hyunju Liu; Su-Mi Lee; Hosouk Joung
Journal:  J Muscle Res Cell Motil       Date:  2021-06-17       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.